ARCHIVES

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

DCT Advisors OKDTP Recompetitions Pas In Radiology

November 15, 1991

Study: Gene Assay Can Provide Valid Prognostic Information

January 31, 2014

NRC Group Splits Over chemical Dose Testing For Carcinogenicity

March 12, 1993

Mammography Quality Standards Set, FDA User Fees Enacted; Oral Cancer Drugs Covered

October 16, 1992

Interview: Joseph Jacobs Claims “Political Extortion” By The “Harkinites”

October 14, 1994

American Cancer Society Publishes CT Screening Guidelines for Lung Cancer

January 11, 2013